Effects of Combined Treatment With Rapamycin and Cotylenin A, a Novel Differentiation-Inducing Agent, on Human Breast Carcinoma McF-7 Cells and Xenografts
Breast Cancer Research - United Kingdom
doi 10.1186/bcr1344
Full Text
Open PDFAbstract
Available in full text
Date
November 9, 2005
Authors
Publisher
Springer Science and Business Media LLC